MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ONC made $1,412,284K in revenue. $124,841K in net income. Net profit margin of 8.84%.

Income Overview

Revenue
$1,412,284K
Net Income
$124,841K
Net Profit Margin
8.84%
EPS
$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
    • Brukinsa
    • Tevimbra
    • Xgeva
    • Others
Revenue Breakdown
    • Product
    • Product
    • Revenue From Contract With Custo...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
Total revenues
1,412,284
Cost of sales - product-Product
196,510
Gross profit
1,215,774
Research and development
523,662
Selling, general and administrative
528,998
Total operating expenses
1,052,660
Income (loss) from operations
163,114
Interest income, net
3,029
Other (expense) income, net
-18,979
Income (loss) before income taxes
147,164
Income tax expense
22,323
Net income (loss)
124,841
Basic (in dollars per share)
0.09
Diluted (in dollars per share)
0.08
Weighted-average shares outstanding diluted (in shares)
1,488,750,354
Weighted-average shares outstandingbasic (in shares)
1,432,801,699
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Collaboration Other$987K Novartis Broad MarketsRevenue$4,115K Amgen Royalty Revenue$12,169K Other$20,112K POBEVCY$10,499K KYPROLIS$18,369K BLINCYTO$30,476K Xgeva$84,243K Tevimbra$190,623K Brukinsa$1,040,691K Other Revenue$17,271K Product$1,395,013K Total revenues$1,412,284K Gross profit$1,215,774K Cost of sales -product-Product$196,510K Interest income, net$3,029K Income (loss) fromoperations$163,114K Total operatingexpenses$1,052,660K Income (loss) beforeincome taxes$147,164K Other (expense)income, net-$18,979K Selling, general andadministrative$528,998K Research and development$523,662K Net income (loss)$124,841K Income tax expense$22,323K

BeOne Medicines Ltd. (ONC)

BeOne Medicines Ltd. (ONC)